Notably, we found that autophagy was significantly activated along with an increased LC3 II/I ratio and degradation of p62 after metformin treatment in cervical cancer (HeLa), prostate cancer (PC‐3) and breast cancer (MDA‐MB‐231) cells (Figure S4), which is in accordance with other studies. Here, MAP1LC3A is linked to breast carcinoma.